Predictions
Cenovus Energy Inc.
Start price
Target price
Perf. (%)
€16.65
04.10.24
04.10.24
€28.26
04.10.25
04.10.25
0.00%
04.10.24
04.10.24
GAIL India Ltd. ADR
Start price
Target price
Perf. (%)
€15.20
03.10.24
03.10.24
€15.00
03.10.25
03.10.25
0.00%
03.10.24
03.10.24
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
India Capital Growth Fund Ltd
Start price
Target price
Perf. (%)
€2.10
03.10.24
03.10.24
€2.00
03.10.25
03.10.25
0.00%
03.10.24
03.10.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
India Globalization Capital
Start price
Target price
Perf. (%)
€0.35
02.10.24
02.10.24
€0.000
02.10.25
02.10.25
0.00%
03.10.24
03.10.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€44.06
01.10.24
01.10.24
€66.93
01.10.25
01.10.25
-0.50%
03.10.24
03.10.24
Check Cap Ltd
Start price
Target price
Perf. (%)
€1.06
30.09.24
30.09.24
-
30.09.25
30.09.25
23.58%
03.10.24
03.10.24
Probably not worthwhile Investment
Little innovation
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.84
28.09.24
28.09.24
-
28.09.25
28.09.25
-
28.09.24
28.09.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.22
28.09.24
28.09.24
-
28.09.25
28.09.25
-
15.12.23
15.12.23
GAIL India Ltd. ADR
Start price
Target price
Perf. (%)
€15.70
28.09.24
28.09.24
€15.00
28.09.25
28.09.25
-3.18%
03.10.24
03.10.24
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Cassava Sciences Inc.
Start price
Target price
Perf. (%)
€25.72
28.09.24
28.09.24
€12.00
28.09.25
28.09.25
-4.12%
04.10.24
04.10.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
negative Cash Flow expected
Bad rating
Adicet Bio Inc.
Start price
Target price
Perf. (%)
€1.22
28.09.24
28.09.24
€12.00
28.09.25
28.09.25
5.68%
04.10.24
04.10.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected